DVAX250516C10000
- 0.73
- -0.17-18.89%
Dynavax Technologies Newsroom
Why Investors Shouldn't Be Surprised By Dynavax Technologies Corporation's (NASDAQ:DVAX) 25% Share Price Plunge
Dynavax Technologies Analyst Ratings
Express News | Dynavax Technologies Corp - Urges Stockholders to Vote 'for' All Four Co's Director Nominees
Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders
Goldman Sachs Maintains Dynavax Technologies(DVAX.US) With Sell Rating, Cuts Target Price to $10
Dynavax, Deep Track Capital Step Up Fight Ahead of June 11 Annual Meeting
Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots.
Express News | Shares of Vaccine Stocks Are Trading Lower After CDC Advisers Begins a Review of Vaccine Guidelines and Discussed a More Narrow Use of COVID-19 Booster Shots
Express News | Deep Track: Dynavax Technologies' Board Rejects Nomination of Four Candidates to Its Board
Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Dynavax Technologies (NASDAQ:DVAX) Pulls Back 6.5% This Week, but Still Delivers Shareholders Strong 31% CAGR Over 5 Years
Are Dynavax Technologies Corporation's (NASDAQ:DVAX) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness?
Express News | Reported Earlier, CenterPoint Energy Moves To Reduce Electric Bills By Up To $2 Monthly By 2027
Dynavax Files Preliminary Proxy Statement
Recursion Bolsters Board of Directors With Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
New York Manufacturing Hits Low, Inflation Fears Rise
Wall Street Analysts See an 83.1% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
Insider Sale: President & COO of $DVAX Sells 32,764 Shares